Tamtam Try Tamtam free
Corteva Agriscience logo

Corteva Agriscience account plan

Agricultural solutions provider

At a glance

Corteva is an Indianapolis crop protection company (NYSE: CTVA); its crop protection segment had $7,503 million of 2025 net sales before the seed spin-off.

Corteva, Inc. (NYSE: CTVA), headquartered in Indianapolis, Indiana, became a pure crop protection company on October 1, 2026, when it spun off its Seed business as Vylor Inc. It sells herbicides, insecticides, fungicides, biologicals, nitrogen stabilizers and seed-applied technologies to growers in approximately 110 countries, competing with BASF, Bayer, FMC, Syngenta and ChemChina and with generic producers. Before the split, the combined company had FY2025 net sales of $17,401 million, income from continuing operations of $1,204 million, operating EBITDA of $3,848 million and approximately 21,500 employees at December 31, 2025. The Crop Protection segment, the scope of today's Corteva, had 2025 net sales of $7,503 million and segment operating EBITDA of $1,350 million. Luke Kissam is CEO.

Business units

Strategic priorities

Innovation-led growth
The standalone company rests growth on its R&D pipeline, put at $11 billion, and plans 12 new products over the next decade, including five biologicals with potential of approximately $4 billion of peak revenue. Seven active chemicals launched over the last decade are expected to generate $1.4 billion in 2026.
Defending molecules against generics
Corteva extends the value of active ingredients through new formulations, mixtures and blends with biologicals, and says development must get faster and cheaper; Kissam said nothing major comes off patent by the end of 2028.
Market-specific go-to-market in Brazil
Brazil's crop protection market is sized at $14 billion, where Corteva generates roughly $1.7 billion; it sells directly in the north and through Emblema regional distributors and the Escalas cooperative program in the south, and is re-examining direct sales, co-ops and distribution.
Cost structure overhaul
A third party is reviewing processes, manufacturing footprint, logistics, country and product exits, routes to market and back office, with technology and AI layered on over "the next 4 to 6 to 8 quarters"; a hiring freeze and tighter SG&A are in place.
Balance sheet and capital returns
The CFO targets about $1.5 billion of year-end cash, about $1 billion of financial debt and capex around $200 million a year; the Board authorized the first dividend after the spin, and buybacks are expected in 2027.
Partnerships and licensing
Kissam said Corteva is "open for business" for licensing and partnerships with universities, start-ups and competitors, citing the FMC rimisoxafen deal.

Latest results

In the third quarter of 2026, its first as a standalone crop protection company, Corteva's net sales fell 9 percent to $1,591 million from $1,742 million, with price down 7 percent and volume down 2 percent; adjusted pro forma operating EBITDA was $222 million against $268 million. Latin America fell to $570 million from $791 million on elevated channel inventory and farmer liquidity constraints in Brazil, while North America rose 7 percent, EMEA 12 percent and Asia Pacific 3 percent. New product volumes grew 20 percent. Year to date, net sales were $5,357 million (-1 percent) and adjusted pro forma operating EBITDA was flat at $943 million with a 17.6 percent margin. Full-year 2026 guidance was cut to adjusted pro forma operating EBITDA of $1.1 billion to $1.125 billion and operating EPS of $0.76 to $0.80, a cut the CFO called "100% Brazil driven".

Investments and deals

Seed spin-off
Seed was separated as Vylor Inc. on October 1, 2026; separation costs were $230 million in the first nine months of 2026, and Corteva's revolving credit facility was reduced to $2.0 billion and extended to August 2031.
Crop Protection network restructuring
The Operations Strategy Restructuring Program exits production at Pittsburg, California, and in June 2026 moved to a next phase including the intended cessation of production in Asturias, Spain; a further network optimization is expected to be substantially complete in 2028, with approximately $130 million to $140 million of net pre-tax charges in 2026.
2026 workforce restructuring
Approved March 15, 2026: workforce reductions across commercial and support functions, $70 million to $80 million of severance and an estimated $115 million to $125 million of run-rate savings by 2027.
Bayer resolution
In January 2026 Corteva paid $610 million to settle its disputes with Bayer, ending all litigation between the parties and terminating disputed royalty obligations.

Challenges and risks

Brazil downturn and channel inventory
Kissam said "too much of the product we sold into the Brazil channel last year didn't go to ground", with roughly $250 million of extra revenue in the channel; the Brazilian sellout market is down roughly 12 percent year to date.
Generic and acetochlor price pressure
Price was a roughly $120 million headwind in the third quarter of 2026, about 90 percent from US acetochlor and generic pressure in Brazil; 80 percent of full-year pricing pressure comes from acetochlor and five molecules in Brazil.
Inherited cost base
Kissam said "we simply cannot afford the infrastructure we inherited", and some R&D projects are being paused for a year.
Regulatory complexity
Products are registered country by country, EPA reviews under the Endangered Species Act can add use restrictions, and the 10-K says approval processes "are becoming increasingly more complex".
Legacy PFAS liabilities
PFAS liabilities are shared with Chemours and DuPont under a 2021 memorandum of understanding, and state attorneys general opposed the spin-off over PFAS concerns.

What leadership says

“We executed well against the things we can control. New products performed strongly, productivity delivered, and we generated broad-based organic growth outside Latin America.”

Luke Kissam, Chief Executive Officer · Third-quarter 2026 earnings release, 2026-11-11

“Corteva has a balanced portfolio. We're not a one-trick pony.”

Luke Kissam, Chief Executive Officer · Investor Day coverage, AgNavigator, 2026-09-15

“North and South Brazil are fundamentally different markets, so we don't treat them the same”

Brook Cunningham, Chief Commercial Officer · Investor Day coverage, AgNavigator, 2026-09-15

“we simply cannot afford the infrastructure we inherited.”

Luke Kissam, Chief Executive Officer · Q3 2026 earnings call, 2026-11-12

Where a supplier can help

Cost and footprint transformation
Tied to the cost structure overhaul: consulting, process simplification, logistics and AI tooling for the review of footprint, routes to market and back office over the coming quarters.
Faster, cheaper development
Tied to the generics defence and innovation priorities: formulation, R&D productivity and regulatory data services that shorten development of new mixtures and biologicals.
Brazil route-to-market and credit tools
Tied to the Brazil challenge: channel inventory visibility, distributor credit risk and direct-sales tooling as Corteva re-examines how it sells in Brazil.
Standalone back office
Tied to the seed spin-off: IT, finance and shared-service suppliers helping a newly separated company run without Vylor service arrangements.
Manufacturing network changes
Tied to the restructuring of the crop protection network: contract manufacturing and formulation partners as sites such as Pittsburg and Asturias wind down.

Tamtam's reading of the priorities and challenges above, not the company's own words.

Selling to companies like Corteva Agriscience?

Tamtam finds the companies that match your ideal customer, researches each account and tells you who to contact and when.

Find similar companies

Key documents

Read in full by Tamtam; each summary links to the document itself.

Questions about Corteva Agriscience

What does Corteva do?

Since October 1, 2026 Corteva is a pure crop protection company selling herbicides, insecticides, fungicides, biologicals and seed-applied technologies to growers in approximately 110 countries. Its former Seed business is now Vylor Inc.

What is Corteva's revenue?

The Crop Protection business had 2025 net sales of $7,503 million; the pre-spin combined company reported $17,401 million. For 2026 Corteva guides adjusted pro forma operating EBITDA of $1.1 billion to $1.125 billion.

How many employees does Corteva have?

The combined company employed approximately 21,500 people at December 31, 2025, before the seed spin-off; no post-spin figure is given.

Who leads Corteva?

Luke Kissam is CEO and Jeff Rudolph is CFO of the standalone crop protection company.

What is Corteva's strategy?

Growth through its R&D pipeline, new formulations and mixtures that extend active ingredients, and go-to-market tailored to each market, combined with a broad cost structure review.

Written by Tamtam from the company's own published documents listed above, read in full. Figures are as those documents state them, for the periods they name. (2026-11-17)